The earnings call presented a balanced view of ICON's performance with notable achievements in business awards, cost management, and strategic initiatives. However, these were offset by revenue declines and elevated cancellations due to market volatility.

Company Guidance -

Q3 2025

During ICON Plc's Q2 2025 earnings call, significant guidance was provided on various financial and operational metrics. The company reported a sequential increase in gross business awards by 11% over Q1, driven by biotech customer wins and large pharma partnerships. Q2 revenue was $2.017 billion, with a gross margin of 28.3% and an adjusted EBITDA margin of 19.6%. Adjusted earnings per share rose by 2% to $3.26, despite a net book-to-bill ratio of 1.02x impacted by elevated cancellations. ICON's full-year revenue guidance was increased by $100 million, with a revised range of $7.85 billion to $8.15 billion, while maintaining the midpoint of the adjusted EPS guidance at $13.50. The company also highlighted operational improvements, such as a gross margin increase, SG&A cost reductions, and advancements in key therapeutic areas, particularly in obesity and related metabolic diseases. Additionally, ICON saw encouraging signs in M&A and licensing activities among large pharma companies.

Increased Gross Business Awards

Gross business awards rose 11% sequentially over Q1, driven by notable wins from biotech customers and large pharma partnerships.

Improved Financial Metrics

Revenue performance exceeded expectations with higher pass-through revenue, a stable burn rate of 8.2%, and a gross margin increase to 28.3%.

Cost Management Success

SG&A costs reduced by $9 million year-over-year. Adjusted EBITDA margin increased to 19.6%.

Strategic Investments and Innovations

Launched a Center for Obesity with over 100 U.S. sites, focusing on rapid site activation. Advanced AI tools to enhance service delivery and improve trial start-up times.

Shareholder Returns

Repurchased $250 million in shares and increased share repurchase authorization to $1 billion.

Icon (ICLR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ICLR Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 22, 2025	2025 (Q3)	3.33 / -	3.35	―	―	―
Jul 23, 2025	2025 (Q2)	3.19 / 3.26	3.75	-13.07% (-0.49)
Apr 30, 2025	2025 (Q1)	3.10 / 3.19	3.47	-8.07% (-0.28)
Feb 19, 2025	2024 (Q4)	3.43 / 3.43	3.46	-0.87% (-0.03)
Oct 23, 2024	2024 (Q3)	3.85 / 3.35	3.3	1.52% (+0.05)
Jul 24, 2024	2024 (Q2)	3.68 / 3.75	3.11	20.58% (+0.64)
Apr 24, 2024	2024 (Q1)	3.41 / 3.47	2.9	19.66% (+0.57)
Feb 21, 2024	2023 (Q4)	3.46 / 3.46	3.13	10.54% (+0.33)
Oct 25, 2023	2023 (Q3)	3.27 / 3.30	3	10.00% (+0.30)
Jul 26, 2023	2023 (Q2)	3.08 / 3.11	2.86	8.74% (+0.25)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ICLR Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 23, 2025	$167.89	$195.01	+16.15%
Apr 30, 2025	$151.44	$145.21	-4.11%
Feb 19, 2025	$191.32	$201.84	+5.50%
Oct 23, 2024	$280.76	$221.73	-21.03%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Icon Plc (ICLR) report earnings?

Icon Plc (ICLR) is schdueled to report earning on Oct 22, 2025, After Close (Confirmed).

What is Icon Plc (ICLR) earnings time?

Icon Plc (ICLR) earnings time is at Oct 22, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ICLR EPS forecast?

ICLR EPS forecast for the fiscal quarter 2025 (Q3) is 3.33.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing